Literature DB >> 10738676

Dengue and dengue hemorrhagic fever in Latin America and the Caribbean.

R E Istúriz1, D J Gubler, J Brea del Castillo.   

Abstract

Four serotypes of dengue viruses produce dengue fever, dengue hemorrhagic fever, and dengue shock syndrome. They are the most important arbovirus infections of humans, in terms of both morbidity and mortality, constituting one of the most rapidly expanding and re-emerging infectious disease problems in Latin America. In less than 20 years, the region has transformed itself from hypoendemic to hyperendemic, while serotype circulation in most countries has gone from none or single to multiple. Changes in endemicity have coincided with the emergence and increasing incidence of the severer forms of dengue infection. This article reviews the clinical presentations of these diseases. Health care providers who see patients in or returning from areas of Latin America, the Caribbean, and other tropical areas must consider dengue in the differential diagnosis of patients presenting with compatible symptoms, and must be knowledgeable in the current management of this important disease.

Entities:  

Mesh:

Substances:

Year:  2000        PMID: 10738676     DOI: 10.1016/s0891-5520(05)70221-x

Source DB:  PubMed          Journal:  Infect Dis Clin North Am        ISSN: 0891-5520            Impact factor:   5.982


  16 in total

Review 1.  Dengue: an escalating problem.

Authors:  Robert V Gibbons; David W Vaughn
Journal:  BMJ       Date:  2002-06-29

2.  Seroprevalence of seven zoonotic pathogens in pregnant women from the Caribbean.

Authors:  Heidi Wood; Michael A Drebot; Eric Dewailly; Liz Dillon; Kristina Dimitrova; Martin Forde; Allen Grolla; Elise Lee; Amanda Loftis; Kai Makowski; Karen Morrison; Lyndon Robertson; Rosina C Krecek
Journal:  Am J Trop Med Hyg       Date:  2014-06-09       Impact factor: 2.345

3.  Cost-effective real-time reverse transcriptase PCR (RT-PCR) to screen for Dengue virus followed by rapid single-tube multiplex RT-PCR for serotyping of the virus.

Authors:  Yee-Ling Lai; Youne-Kow Chung; Hwee-Cheng Tan; Hoon-Fang Yap; Grace Yap; Eng-Eong Ooi; Lee-Ching Ng
Journal:  J Clin Microbiol       Date:  2007-01-10       Impact factor: 5.948

4.  Evaluation of widely used diagnostic tests to detect West Nile virus infections in horses previously infected with St. Louis encephalitis virus or dengue virus type 2.

Authors:  Jeremy P Ledermann; Maria A Lorono-Pino; Christine Ellis; Kali D Saxton-Shaw; Bradley J Blitvich; Barry J Beaty; Richard A Bowen; Ann M Powers
Journal:  Clin Vaccine Immunol       Date:  2011-02-23

5.  An RNA cap (nucleoside-2'-O-)-methyltransferase in the flavivirus RNA polymerase NS5: crystal structure and functional characterization.

Authors:  Marie-Pierre Egloff; Delphine Benarroch; Barbara Selisko; Jean-Louis Romette; Bruno Canard
Journal:  EMBO J       Date:  2002-06-03       Impact factor: 11.598

6.  Knowledge, attitudes and practices regarding dengue infection in Westmoreland, Jamaica.

Authors:  F Shuaib; D Todd; D Campbell-Stennett; J Ehiri; P E Jolly
Journal:  West Indian Med J       Date:  2010-03       Impact factor: 0.171

7.  Recent Advances and New Challenges in Travel Medicine.

Authors:  Lin H. Chen; Mary E. Wilson
Journal:  Curr Infect Dis Rep       Date:  2002-02       Impact factor: 3.663

Review 8.  Dengue--quo tu et quo vadis?

Authors:  Rubing Chen; Nikos Vasilakis
Journal:  Viruses       Date:  2011-09-01       Impact factor: 5.048

9.  Genetic variation in the 3' untranslated region of dengue virus serotype 3 strains isolated from mosquitoes and humans in Brazil.

Authors:  Márcia Gonçalves de Castro; Fernanda Bruycker de Nogueira; Rita Maria Ribeiro Nogueira; Ricardo Lourenço-de-Oliveira; Flávia Barreto dos Santos
Journal:  Virol J       Date:  2013-01-02       Impact factor: 4.099

10.  Emergence and global spread of a dengue serotype 3, subtype III virus.

Authors:  William B Messer; Duane J Gubler; Eva Harris; Kamalanayani Sivananthan; Aravinda M de Silva
Journal:  Emerg Infect Dis       Date:  2003-07       Impact factor: 6.883

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.